BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 31445233)

  • 1. Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
    Kumar R; Saha N; Purohit P; Garg SK; Seth K; Meena VS; Dubey S; Dave K; Goyal R; Sharma SS; Banerjee UC; Chakraborti AK
    Eur J Med Chem; 2019 Nov; 182():111601. PubMed ID: 31445233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New pyridazine derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents; design, synthesis and biological evaluation.
    Ahmed EM; Hassan MSA; El-Malah AA; Kassab AE
    Bioorg Chem; 2020 Jan; 95():103497. PubMed ID: 31838289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of pyridazinone derivatives as selective COX-2 inhibitors and potential anti-inflammatory agents.
    Ahmed EM; Kassab AE; El-Malah AA; Hassan MSA
    Eur J Med Chem; 2019 Jun; 171():25-37. PubMed ID: 30904755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel sulindac derivatives: synthesis, characterisation, evaluation of antioxidant, analgesic, anti-inflammatory, ulcerogenic and COX-2 inhibition activity.
    Bhat MA; Al-Omar MA; Alsaif NA; Almehizia AA; Naglah AM; Razak S; Khan AA; Ashraf NM
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):921-934. PubMed ID: 32238055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of phthalimide derivatives as potential cyclooxygenase-2 (COX-2) inhibitors: anti-inflammatory and analgesic activities.
    Alanazi AM; El-Azab AS; Al-Suwaidan IA; ElTahir KE; Asiri YA; Abdel-Aziz NI; Abdel-Aziz AA
    Eur J Med Chem; 2015 Mar; 92():115-23. PubMed ID: 25549551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.
    Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES
    Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
    Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
    Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory activity.
    Halim PA; Georgey HH; George MY; El Kerdawy AM; Said MF
    Bioorg Chem; 2021 Oct; 115():105253. PubMed ID: 34390973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Thioxoimidazolidine-2-one derivatives: Synthesis, anti-inflammatory activity, analgesic activity, COX inhibition assay and molecular modelling study.
    El-Sharief MAMS; Abbas SY; El-Sharief AMS; Sabry NM; Moussa Z; El-Messery SM; Elsheakh AR; Hassan GS; El Sayed MT
    Bioorg Chem; 2019 Jun; 87():679-687. PubMed ID: 30953887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation and docking analysis of 3-methyl-1-phenylchromeno[4,3-c]pyrazol-4(1H)-ones as potential cyclooxygenase-2 (COX-2) inhibitors.
    Grover J; Kumar V; Sobhia ME; Jachak SM
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4638-4642. PubMed ID: 25219899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations.
    Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA
    Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
    Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
    Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, anti-inflammatory, analgesic and COX-1/2 inhibition activities of anilides based on 5,5-diphenylimidazolidine-2,4-dione scaffold: Molecular docking studies.
    Abdel-Aziz AA; El-Azab AS; Abou-Zeid LA; ElTahir KE; Abdel-Aziz NI; Ayyad RR; Al-Obaid AM
    Eur J Med Chem; 2016 Jun; 115():121-31. PubMed ID: 26999325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
    Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK
    Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of pyrazole-based compounds with 1,2,4-triazole-3-thiol moiety as selective COX-2 inhibitors cardioprotective drug candidates: Design, synthesis, cyclooxygenase inhibition, anti-inflammatory, ulcerogenicity, cardiovascular evaluation, and molecular modeling studies.
    Abdellatif KRA; Abdelall EKA; Elshemy HAH; Philoppes JN; Hassanein EHM; Kahk NM
    Bioorg Chem; 2021 Sep; 114():105122. PubMed ID: 34243075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel halogenated triarylpyrazoles as selective COX-2 inhibitors: Anti-inflammatory activity, histopatholgical profile and in-silico studies.
    Abdellatif KRA; Abdelall EKA; Labib MB; Fadaly WAA; Zidan TH
    Bioorg Chem; 2020 Dec; 105():104418. PubMed ID: 33166844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
    Bakr RB; Ghoneim AA; Azouz AA
    Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of phenylpiperazine derivatives of 1,4-benzodioxan as selective COX-2 inhibitors and anti-inflammatory agents.
    Sun J; Wang S; Sheng GH; Lian ZM; Liu HY; Zhu HL
    Bioorg Med Chem; 2016 Nov; 24(21):5626-5632. PubMed ID: 27658794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1,2,4-triazine as selective cyclooxygenase-2 inhibitors.
    Irannejad H; Kebriaieezadeh A; Zarghi A; Montazer-Sadegh F; Shafiee A; Assadieskandar A; Amini M
    Bioorg Med Chem; 2014 Jan; 22(2):865-73. PubMed ID: 24361187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.